Literature DB >> 17644085

A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.

Viktor R Drel1, Pal Pacher, Igor Vareniuk, Ivan Pavlov, Olga Ilnytska, Valeriy V Lyzogubov, Jyoti Tibrewala, John T Groves, Irina G Obrosova.   

Abstract

Whereas an important role of free radicals and oxidants in peripheral diabetic neuropathy is well established, the contribution of nitrosative stress and, in particular, of the highly reactive oxidant peroxynitrite, has not been properly explored. Our previous findings implicate peroxynitrite in diabetes-associated motor and sensory nerve conduction deficits and peripheral nerve energy deficiency and poly(ADP-ribose) polymerase activation associated with Type 1 diabetes. In this study the role of nitrosative stress in diabetic sensory neuropathy is evaluated. The peroxynitrite decomposition catalyst Fe(III) tetrakis-2-(N-triethylene glycol monomethyl ether)pyridyl porphyrin (FP15) was administered to control and streptozotocin (STZ)-diabetic mice at the dose of 5 mg kg(-1) day(-1) (FP15), for 3 weeks after initial 3 weeks without treatment. Mice with 6-week duration of diabetes developed clearly manifest thermal hypoalgesia (paw withdrawal, tail-flick, and hot plate tests), mechanical hypoalgesia (tail pressure Randall-Sellito test), tactile allodynia (flexible von Frey filament test), and approximately 38% loss of intraepidermal nerve fibers. They also had increased nitrotyrosine and poly(ADP-ribose) immunofluorescence in the sciatic nerve, grey matter of spinal cord, and dorsal root ganglion neurons. FP15 treatment was associated with alleviation of thermal and mechanical hypoalgesia. Tactile response threshold tended to increase in response to peroxynitrite decomposition catalyst treatment, but still remained approximately 59% lower compared with non-diabetic controls. Intraepidermal nerve fiber density was 25% higher in FP15-treated than in untreated diabetic rats, but the difference between two groups did not achieve statistical significance (p=0.054). Nitrotyrosine and poly(ADP-ribose) immunofluorescence in sciatic nerve, spinal cord, and dorsal root ganglion neurons of peroxynitrite decomposition catalyst-treated diabetic mice were markedly reduced. In conclusion, nitrosative stress plays an important role in sensory neuropathy associated with Type 1 diabetes. The findings provide rationale for further studies of peroxynitrite decomposition catalysts in a long-term diabetic model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644085      PMCID: PMC2225472          DOI: 10.1016/j.ejphar.2007.05.055

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  50 in total

1.  Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.

Authors:  Viktor R Drel; Pal Pacher; Martin J Stevens; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2006-01-31       Impact factor: 7.376

2.  Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats.

Authors:  Fei Li; Omorodola I Abatan; Howard Kim; Diana Burnett; Dennis Larkin; Irina G Obrosova; Martin J Stevens
Journal:  Neurobiol Dis       Date:  2006-04-19       Impact factor: 5.996

3.  Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.

Authors:  Eric C M Ho; Karen S L Lam; Yuk Shan Chen; Johnny C W Yip; Meena Arvindakshan; Shin-Ichiro Yamagishi; Soroku Yagihashi; Peter J Oates; Craig A Ellery; Stephen S M Chung; Sookja K Chung
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

4.  Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.

Authors:  Olga Ilnytska; Valeriy V Lyzogubov; Martin J Stevens; Viktor R Drel; Nazar Mashtalir; Pal Pacher; Mark A Yorek; Irina G Obrosova
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

5.  Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.

Authors:  Csaba Szabó; Alisha Biser; Rita Benko; Erwin Böttinger; Katalin Suszták
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

6.  Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats.

Authors:  M J Stevens; F Li; V R Drel; O I Abatan; H Kim; D Burnett; D Larkin; I G Obrosova
Journal:  J Pharmacol Exp Ther       Date:  2006-10-04       Impact factor: 4.030

7.  The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.

Authors:  Viktor R Drel; Nazar Mashtalir; Olga Ilnytska; Jeho Shin; Fei Li; Valeriy V Lyzogubov; Irina G Obrosova
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

Review 8.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

9.  Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.

Authors:  Igor Vareniuk; Ivan A Pavlov; Viktor R Drel; Valeriy V Lyzogubov; Olga Ilnytska; Seth R Bell; Jyoti Tibrewala; John T Groves; Irina G Obrosova
Journal:  Exp Neurol       Date:  2007-03-27       Impact factor: 5.330

10.  Remote neurotrophic support of epidermal nerve fibres in experimental diabetes.

Authors:  C Toth; V Brussee; D W Zochodne
Journal:  Diabetologia       Date:  2006-03-10       Impact factor: 10.122

View more
  34 in total

1.  Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.

Authors:  Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Yury Maksimchyk; Tamara M Kuchmerovska; Jerry L Nadler; Irina G Obrosova
Journal:  Exp Neurol       Date:  2011-04-16       Impact factor: 5.330

2.  Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Hanna Shevalye; Sergey Lupachyk; Alexander Obrosov; John T Groves; Irina G Obrosova; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

Review 3.  Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

Authors:  Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

Review 4.  Cardiovascular autonomic neuropathies as complications of diabetes mellitus.

Authors:  Michael Kuehl; Martin J Stevens
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

5.  Anti-superoxide and anti-peroxynitrite strategies in pain suppression.

Authors:  Kali Janes; William L Neumann; Daniela Salvemini
Journal:  Biochim Biophys Acta       Date:  2011-12-19

Review 6.  Diabetic neuropathic pain: Physiopathology and treatment.

Authors:  Anne K Schreiber; Carina Fm Nones; Renata C Reis; Juliana G Chichorro; Joice M Cunha
Journal:  World J Diabetes       Date:  2015-04-15

7.  Manganese(III) complexes of bis(hydroxyphenyl)dipyrromethenes are potent orally active peroxynitrite scavengers.

Authors:  Smita Rausaria; Andrew Kamadulski; Nigam P Rath; Leesa Bryant; Zhoumou Chen; Daniela Salvemini; William L Neumann
Journal:  J Am Chem Soc       Date:  2011-03-03       Impact factor: 15.419

Review 8.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

Review 9.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.

Authors:  Irina G Obrosova; Weizheng Xu; Valeriy V Lyzogubov; Olga Ilnytska; Nazar Mashtalir; Igor Vareniuk; Ivan A Pavlov; Jie Zhang; Barbara Slusher; Viktor R Drel
Journal:  Free Radic Biol Med       Date:  2007-10-03       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.